Article info
PDFMovement disorders
Review
Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers
- Correspondence to Prof Huw R Morris, Department of Clinical Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; h.morris{at}ucl.ac.uk
Citation
Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers
Publication history
- Received February 13, 2017
- Revised April 12, 2017
- Accepted April 13, 2017
- First published June 9, 2017.
Online issue publication
February 01, 2018
Article Versions
- Previous version (28 November 2017).
- Previous version (28 November 2017).
- Previous version (28 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.